JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2020/01/02
-
Journal
-
Indian UGC (journal)
-
Refrences23
-
Citations77
-
Elisabetta Miserocchi
-
Chiara Giuffrè
-
Martina Cornalba
-
Irene Pontikaki
-
Rolando Cimaz
Cite
Miserocchi, Elisabetta, et al. “JAK Inhibitors in Refractory Juvenile Idiopathic Arthritis-Associated Uveitis”. Clinical Rheumatology, vol. 39, no. 3, 2020, pp. 847-51, https://doi.org/10.1007/s10067-019-04875-w.
Miserocchi, E., Giuffrè, C., Cornalba, M., Pontikaki, I., & Cimaz, R. (2020). JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis. Clinical Rheumatology, 39(3), 847-851. https://doi.org/10.1007/s10067-019-04875-w
Miserocchi, Elisabetta, Chiara Giuffrè, Martina Cornalba, Irene Pontikaki, and Rolando Cimaz. “JAK Inhibitors in Refractory Juvenile Idiopathic Arthritis-Associated Uveitis”. Clinical Rheumatology 39, no. 3 (2020): 847-51. https://doi.org/10.1007/s10067-019-04875-w.
Miserocchi E, Giuffrè C, Cornalba M, Pontikaki I, Cimaz R. JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis. Clinical Rheumatology. 2020;39(3):847-51.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the musculoskeletal system
Medicine
Medicine (General)
You May Also Like
- Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis
- Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
- Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014
- The Incidence of Fibromyalgia and Its Associated Comorbidities
- Immunologic Mechanisms in the Pathogenesis of Rheumatoid Arthritis
Refrences
Refrences Analysis
The category
Medicine: Medicine (General) 18
is the most frequently represented among the references in this article. It primarily includes studies from The Journal of Rheumatology The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Citations Analysis
The category
Medicine: Medicine (General) 40
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Biotherapies in Uveitis and was published in 2020. The most recent citation comes from a 2024 study titled Tofacitinib for Refractory Uveitis and Scleritis in Children: A Case Series. This article reached its peak citation in 2022, with 25 citations. It has been cited in 51 different journals, 27% of which are open access. Among related journals, the Expert Review of Clinical Immunology cited this research the most, with 6 citations. The chart below illustrates the annual citation trends for this article.